Roche Group
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
SwitzerlandWebsite
www.rdmeacademy.comRevenue
<$5 MillionIndustry
About Roche Group
Roche Group Org Chart
Is Roche Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Roche Group has recently received funding, and reach out quickly before it becomes old news!
Check out if Roche Group is spiking on competitors!
Funding: Get notified immidiatlly once Roche Group has new funding data
Click to see if Roche Group had a recent Job posting/layoffs
Earning: See what the market has to say on Roche Group recently announced quarterly report
Website visits: Recent activity has been detected on your website
Roche Group, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Roche Group
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Roche Group launches new products
Recommended Actions
Reach out to Masked Content who joined Roche Group as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Roche Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Roche Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Roche Group.
Roche Group Tech Stack
A closer look at the technologies used by Roche Group
Roche Group News & Media
TRC Remediation Project at Roche Nutley Site in New Jersey Wins National Grand Prize for Sustainability
TRC has been awarded the 2019 Grand Prize for Environmental Sustainability by the American Academy of Environmental Engineers & Scientists for the cleanup of the former Roche site in Nutley, N.J. (PRWeb May 07, 2019) Read the full story at https://www.prweb.com/releases/trc_remediation_project_at_roche_nutley_site_in_new_jersey_wins_national_grand_prize_for_sustainability/prweb16292448.htmPhase III IMpassion130 study showed Roche's Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer
Basel, 2 July 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpassion130 study met its co-primary endpoint of progression-free survival (PFS). Results demonstrated that the combination of Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]), as an initial (first-line) treatment, significantly reduced the risk of disease worsening or death (PFS) in the intention-to treat and PD-L1 positive population with metastatic or u
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Roche Group
Roche Group is a company that operates in the Medical Devices & Equipment industry. It employs 10to19 people and has 1Mto5M of revenue. The company is headquartered in Switzerland.... Read More